Advanced Crohn’s Therapies Show Similar Safety

Large claims analysis finds no significant differences in serious infections, blood clots, or major cardiovascular events across biologics and a Janus kinase inhibitor.

• By

• Doug Brunk

• February 19, 2026

• 2 min

• Conexiant